Paper20430905
Pharmacokinetics and pharmacodynamics of docetaxel with or without ketoconazole modulation in chemonaive breast cancer patients.
Lim YW and 12 others. Ann Oncol, 2010. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Pharmacokinetics and pharmacodynamics of docetaxel with or without ketoconazole modulation in chemonaive breast cancer patients. Papers, record 20430905. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20430905
- Disease
- breast cancer1,032 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Breast Neoplasms | Major topic |
| Area Under Curve | |
| Docetaxel | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Ketoconazole | |
| Maximum Tolerated Dose | |
| Neoplasm Staging | |
| Survival Rate | |
| Taxoids | |
| Treatment Outcome |
Source PubMed
Trials4
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00212082 | Gene Expression Profiles in Predicting Chemotherapy Response in Breast Cancer | Derived from the trial | Yes | ClinicalTrials.gov |
| NCT00212095 | Docetaxel Combined With Ketoconazole in Treatment of Breast Cancer | Derived from the trial | Yes | ClinicalTrials.gov |
| NCT01227733 | Comparative Genomic and Genetic Analysis of Paired Primary Breast - Metastatic Tumor Specimens Using High-throughput Platforms | Background | ClinicalTrials.gov | |
| NCT01247467 | Analysis of Prognostic and Predictive Genomic Signatures Using Archival Paraffin-embedded Breast Tumor - a Pilot Study | Background | ClinicalTrials.gov |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41262581 | Crescent-Shaped Xanthone-Benzimidazole Conjugates as New Target Probes for Telomeric G‑Quadruplex DNA and Specific Cytotoxicity on Cancer Cells. | ACS Pharmacol Transl Sci | 2025 | https://conductscience.org/library/papers/41262581 | PubMed |
| 39768178 | Co-Inhibition of tGLI1 and GP130 Using FDA-Approved Ketoconazole and Bazedoxifene Is Synergistic Against the Growth and Metastasis of HER2-Enriched and Triple-Negative Breast Cancers. | Cells | 2024 | https://conductscience.org/library/papers/39768178 | PubMed |
| 39161139 | A Cross-sectional Comparative Analysis of Eleven Population Pharmacokinetic Models for Docetaxel in Chinese Breast Cancer Patients. | Curr Drug Metab | 2024 | https://conductscience.org/library/papers/39161139 | PubMed |
| 36077791 | An FDA-Approved Antifungal, Ketoconazole, and Its Novel Derivative Suppress tGLI1-Mediated Breast Cancer Brain Metastasis by Inhibiting the DNA-Binding Activity of Brain Metastasis-Promoting Transcription Factor tGLI1. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36077791 | PubMed |
| 36067975 | Repurposing antifungal drugs for cancer therapy. | J Adv Res | 2023 | https://conductscience.org/library/papers/36067975 | PubMed |
| 35399310 | Influence of Concomitant Polypharmacy on Docetaxel-induced Febrile Neutropenia. | Cancer Diagn Progn | 2021 | https://conductscience.org/library/papers/35399310 | PubMed |
| 35378926 | Clotrimazole Inhibits HCC Migration and Invasion by Modulating the ERK-p65 Signaling Pathway. | Drug Des Devel Ther | 2022 | https://conductscience.org/library/papers/35378926 | PubMed |
| 35083840 | Targeted Nanoparticle for Co-delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+ Breast Cancer: Efficacy in Breast Tumor and Brain Metastasis. | Small | 2022 | https://conductscience.org/library/papers/35083840 | PubMed |
| 33986386 | Repurposing ketoconazole as an exosome directed adjunct to sunitinib in treating renal cell carcinoma. | Sci Rep | 2021 | https://conductscience.org/library/papers/33986386 | PubMed |
| 33062889 | ARe we there yet? Understanding androgen receptor signaling in breast cancer. | NPJ Breast Cancer | 2020 | https://conductscience.org/library/papers/33062889 | PubMed |
| 30481959 | Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway. | ACS Nano | 2018 | https://conductscience.org/library/papers/30481959 | PubMed |
| 28496479 | A Comparison of Hepatocyte Cytotoxic Mechanisms for Docetaxel and PLGA-Docetaxel Nanoparticls. | Iran J Pharm Res | 2017 | https://conductscience.org/library/papers/28496479 | PubMed |
| 26582454 | Pharmacokinetics and safety of cyclophosphamide and docetaxel in a hemodialysis patient with early stage breast cancer: a case report. | BMC Cancer | 2015 | https://conductscience.org/library/papers/26582454 | PubMed |
| 21692829 | Effect of grapefruit juice on the pharmacokinetics of docetaxel in cancer patients: a case report. | Br J Clin Pharmacol | 2011 | https://conductscience.org/library/papers/21692829 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CYP3A4 | 1576 | PubTator's text mining | https://conductscience.org/library/genes/1576 |
Source NCBI Gene
Drugs3
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| KETOCONAZOLE | CHEMBL157101 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL157101 | ChEMBL |
| DOCETAXEL | CHEMBL3545252 | Derived from the trial | 2 | https://conductscience.org/library/drugs/CHEMBL3545252 | ChEMBL |
| DOXORUBICIN | CHEMBL53463 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL53463 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20430905
GET https://conductscience.org/api/papers/v1/20430905/authors